“Gynaecological cancer screening” or “cervical screening?” The case of Hungary

In Hungary, "gynaecological cancer screening" by gynaecologists having interest in oncology has had a long history. The screening tool was colposcopy alone embedded in complete gynaecological examination. Later on smear-taking for cytology has been added. This screening protocol has survived until now both in the gynaecological community and public. In the meantime, as it proved its effectiveness, cytological examination has been internationally recommended, as sole method of organized cervical screening; in case of non-negative test result, gynaecological examination including colposcopy is justified. Smear-taking can be undertaken by trained paramedical personnel. The authors have made an attempt to argue the use of "cervical screening" instead of "gynaecological cancer screening", which is deeply entrenched into both professional and public consciousness in Hungary.

Cervical screening; Colposcopy; Cytology; Health visitors.

[1] Läära E., Day N.E., Hakama M.: “Trends in mortality from cervical cancer in the Nordic countries: association with the organized screening programmes”. Lancet, 1987, 1, 1247.

[2] Council of the European Union: “Council recommendation of 2 December 2003 on cancer screening (2003/878/EC)”. Official J. Eur. Union, 2003, 373, 34.

[3] Arbyn M., Anttila A., Jordan J.: “European Guidelines for Quality Assurance in Cervical Cancer Screening”. 2nded. Luxembourg: Office for Official Publications of the European Communities, 2008.

[4] Döbrőssy L.: “Five decades of cervical screening in Hungary”. Nőgyógy. Onkol., 2007, 12, 5. [In Hungarian]

[5] Döbrőssy L., Bodó M., Sugár J.: “The status and prospects of cytological mass screening in Hungary”. Orv. Hetil., 1977, 118, 2121. [In Hungarian]

[6] National Cancer Institute and National Institute of Obstetrics and Gynaecology: “Methodological letter on gynaecological cancer screening”. Orv. Hetil., 1977, 118, 2159. [In Hungarian]

[7] Bodó M., Cseh I., Bősze P.: “Alarm-situation in the cervix programmes: questions and challenges”. Magy. Nőorv. Lapja, 1991, 54, 373. [In Hungarian]

[8] Hakama M., Miller A.B., Day N.E.: “Screening for cancer of the uterine cervix”. Lyon: IARC Sci. Publ. No. 76, 1986.

[9] Döbrőssy L: “Efforts to modernise cervical screening in Hungary: the catalytic role of World Bank Programme”. Népegészségügy.,1999, 5, 23. [In Hungarian]

[10] Kovács A., Döbrőssy L., Budai A., Cornides Á., Boncz I.: “The status of public health screening in Hungary in 2006”. Orv. Hetil., 2007. 148, 435. [In Hungarian]

[11] Döbrőssy L., Kovács A., Budai A., Odor A., Fehér E.: “Screening for cervical cancer in Hungary: New role for health visitors”. Clin. Nurs. Studies, 2013, 1, 32.

[12] Döbrőssy L., Kovács A., Budai A., Odor A., Fehér E.: “Education and training of health visitors to undertake cervical screening”. J.Nurs. Educ. Training, 2015, 5, 28.[13] Wilson J.M.G., Junger G.: “Principles and practice of screening for disease”. Geneva: WHO. Publ. Health Papers no. 34, 1968.

[14] International Agency for Research on Cancer (IARC): “Cervix cancer screening”. Lyon: IARC Handbooks of Cancer Prevention, IARC Press, 2005, 10.

[15] Jordan J., Arbyn M., Martin-Hirsch P., Schenck U., Baldauf J.J., Da Silva D., et al.: “European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1”. Cytopathology, 2008, 19, 342.

[16] Pap Z.: “Handbook of obstetrics and gynaecology”. Budapest: Semmelweis Publishing House, 2009.

[17] Bősze P. Screening and prevention of uterincervix: tradition and new directions. (In Hungarian). Nőgyógy. Onkol., 2008, 13, 10. [In Hungarian]

[18] Hinselmann H.: “Verbesserung der Inspectionsmöglichkeiten von Vulva, Vagina und Portio”. Münchener Med. Wochenschr., 1925, 72, 1733. [In German]

[19] Saslow D., Solomon D., Lawson H.W., Killackey M., Kulasinga S., Garcia F.A.R., et al.: “Screening guidelines for the prevention and early detection of cervical cancer”. CA Cancer J. Clin., 2012, 62, 147.

[20] Bősze P., Szirtes J., Babarczi E., Kulka J.: “Basics of colposcopy. Part 1”. Nőgyógy. Onkol., 2010, 15, 27. [In Hungarian]

[21] Bősze P., Szirtes J., Babarczi E., Kulka J.: “Basics of colposkpy. Part 2”. Nőgyógy. Onkol., 2010, 15, 43. [In Hungarian]

[22] Pretorius R.G., Zhang, Belinson J.L., Huang M.N., Wu L.Y.: “Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse”. Am. J. Obstet. Gynecol., 2004, 191, 430.

[23] Underwood M., Arbyn M., Parry-Smith W., De Bellis-Ayres S., Todd R., Redman C.W.E., Moss E.L.: “Accuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis”. BJOG, 2012, 119, 1293.

[24] Sellors J.W., Sankaranarayanen R.: “Colposcopy and treatment of cervical intraepithelial neoplasia”. Lyon: IARC, 2003, 29.

[25] Kovács A., Döbrőssy L., Budai A., Boncz I., Cornides Á.: “Cervical cancer screening in Hungary: why the “English model” works, and the “Hungarian model” does not?” Eur. J. Gynaecol. Oncol., 2008, 29, 5.

[26] Goldie S.J., Gaffikin L., Goldhaber-Fieber J.D., Gordillo-Tobar A., Levin C., Mahé C., Wright T.C.: “Alliance for Cervical Cancer Prevention Cost Working Group. Cost-effectiveness of cervical cancer screening in five developing countries”. N. Engl. J. Med., 2005, 353, 2158.

[27] Arbyn M., Bergeron C., Klinkhamer P., Martin-Hirsch P., Siebers A.G., Butten J.: “Liquid compared with conventional cervical cytology: a systematic review and metaanalysis”. Obstet. Gynacol., 2008, 111, 157.

[28] Koiss R.: “Screening methods in prevention of cervical cancer”. In: Vanden Broek D., (ed). Human papillomavirus and related diseases. From bench to bedside. Rijeka: InTech, 2012, 65.